Increased bone turnover in the postmenopausal years is a major factor in the development of osteoporosis. Biochemical markers of bone turnover represent a non-invasive, repeatable and relatively inexpensive method of assessing bone turnover. Evidence to date suggests that the most useful role for these markers in the management of individual postmenopausal women will be to monitor early response to preventative therapy or treatment for established osteoporosis.
. CooperC.CompstonJE, eds. Osteoporosis New perspectives of causes, prevention and treatment. London: Royal College of Physicians of London; 1996; 1, Epidemiology and definition of osteoporosis: 1–10.
2.
. Consensus Development Conference.Prophylaxis and treatment of osteoporosis. Am J Med1991; 90 (1): 107–10.
3.
. CalvoMSEyreDRGundbergCMMolecular basis and clinical application of biological markers of bone turnover. Endoc Rev1996; 17 (4): 333–68.
4.
. BlumsohnAHannonRAEastellR.Biochemical assessment of skeletal activity. Physical Medicine and Rehabilitation Clinics of North America1995; 6: 483–505.
5.
. DelmasPDGarneroP.MarcusRFeldmanFKelseyJ. editors. Osteoporosis. San Diego: Academic Press Inc.; 1996; 55, Utility of biochemical markers of bone turnover in osteoporosis: 1075–88.
6.
. EbelingPRAtleyLMGuthrieJRBone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab1996; 81 (9): 3366–71.
. HassagerCColwellAAssiriAMAEffect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links: a longitudinal and cross-sectional study. Clin Endocrinol1992; 37: 45–50.
9.
. UebelhardtDGineytsECChapuyMCDelmasPDUrinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Miner1990; 8: 87–96.
10.
. EastellRDelmasPDHodgsonSFEriksenEFMannKGRiggsBLBone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers. J Clin Endocrinol Metab1988; 67 (4): 741–8.
11.
. GarneroPSornay-RenduEChapuyMCDelmasPDIncreased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res1996; 11: 337–49.
12.
. ChristiansenCRiisBJRodbroP.Prediction of rapid bone loss in postmenopausal women. Lancet1987; I (8542): 1105–8.
13.
. UebelhardtDSchlemmerAJohansenJSEffect of menopause and hormone replacement therapy on the urinary excretion of pyridinium crosslinks. J Clin Endocrinol Metab1991; 72: 367–73.
14.
. MolePAWalkinshawMHRobinsSPPatersonCRCan urinary pyridinium crosslinks and urinary oestrogens predict bone mass and rate of bone loss after the menopause. Eur J Clin Invest1992; 22 (12): 767–71.
15.
. KeenRWNguyenTSobnackRPerryLAThompsonPWSpectorTDCan biochemical markers predict bone loss at the hip and spine?: a 4-year prospective study of 141 early postmenopausal women. Osteoporos Int1996; 6 (5): 399–406.
16.
. Dresner-PollakRParkerRAPokuMBiochemical markers of bone turnover reflect femoral bone loss in elderly women. Calcif Tissue Int1996; 59 (5): 328–33.
17.
. GarneroPHausherrEChapuyMMarkers of bone resorption predict hip fractures in elderly women: the EPIDOS prospective study. J Bone Miner Res1996; 11 (10): 1531–8.
18.
. MeltonLJIIIKhoslaSAtkinsonEJO'FallonWMRiggsBLRelationship of bone turnover to bone density and fracture. J Bone Miner Res1997; 12 (7): 1083–91.
19.
. EastellR.Drug therapy: treatment of postmenopausal osteoporosis. N Engl J Med1998; 338: 736–746.
20.
. TorgersonDJDonaldsonCRussellITReidDMHormone replacement therapy: compliance and cost after screening for osteoporosis. Eur J Obstet Gynecol Reprod Biol1995; 59: 57–60.
21.
. HannonRABlumsohnANaylorKEEastellR.Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability. J Bone Miner Res1998; 13: 1–10.
22.
. StockJLBellNHChestnutCHIIIIncrements in bone mineral density of the lumbar spine and hip and suppression of bone turnover are maintained after discontinuation of alendronate in postmenopausal women. Am J Med1997; 103: 291–297.
23.
. GarneroPShihWJGineytsEKalpfDDelmasPDComparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab1994; 79: 1693–700.
24.
. ChestnutCBellNHClarkGSHormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density. Am J Med1997; 102: 29–37.
